Fibromiyalji Hastalarında Serum Plazma Total Oksidan/Antioksidan, Tiyol-Disülfit ve Asprosin Düzeylerinin İncelenmesi

Öz

Amaç: Fibromiyalji; etiyolojisi belirsiz olan, kas iskelet sistemi bulguları ve birçok somatik semptomun eşlik ettiği kronik bir sendrom olarak tanımlanmaktadır. Bu çalışmada, total antioksidan seviye, total oksidan seviye, tiyol-disülfit homeostazı ve asprosin düzeylerini inceleyip, Fibromiyalji sendromu etyopatogenezine katkı sağlamayı amaçladık. 
Materyal ve metod: Yeni tanılı 20-50 yaş aralığındaki Fibromiyalji sendromlu kadın hastalar ile aynı yaş grubunda sağlıklı gönüllü kadınlar çalışmaya dahil edildi. Her iki grubun plazma natif tiyol, total tiyol, disülfit, natif tiyol/total tiyol, disülfit/natif tiyol, disülfit/total tiyol, total antioksidan seviye, total oksidan seviye ve oksidatif stres indeksi değerleri ile asprosin değerlerine bakıldı. Bulgular: Total antioksidan seviye, total oksidan seviye ve total tiyol seviyeleri hasta grubunda daha düşük; disülfit/natif tiyol oranı hasta grubunda daha yüksek olup; aradaki farklar istatistiksel olarak anlamlı idi (p=0,024, p<0,001, p=0,050, p=0,050). Fibromiyalji sendromu grubunda yaş ile total antioksidan seviye, total tiyol değerleri arasında pozitif korelasyon (r=0,361 p=0,020, r=0,314 p=0,045) ve natif tiyol ile negatif korelasyon (r=0,354 p=0,023) vardı. Fibromiyalji sendromu grubunda vücut kitle indeksi ile asprosin ve total oksidatif seviye arasında pozitif korelasyon (r=0,743 p<0,001, r=0,356 p=0,022); kontrol grubunda vücut kitle indeksi ile total antioksidan seviye arasında negatif korelasyon vardı (r=0,429 p=0,005). Yaygın ağrı indeksi sadece asprosin ile pozitif koreleydi (r=0,309 p=0,049). 
Sonuç: Fibromiyalji sendromunda, serum asprosin düzeyleri gruplar arasında anlamlı farklılık göstermemekle birlikte, vücut kitle indeksi ve yaygın ağrı indeksi ile olan pozitif korelasyonları olası bir ilişkiye işaret edebilir. Bulgularımız ayrıca oksidatif-antioksidatif denge ve tiyol-disülfit homeostazında kısmi bir değişiklik olabileceğini düşündürmektedir.

Anahtar Kelimeler

• Fibromiyalji
• oksidatif stres
• adipokinler
• biyobelirteçler

Destekleyen Kurum

This study was supported with a kit provision by the Scientific Research Commission of HARRAN University (Project No: 20126, Date: November 23, 2020).

Proje Numarası

23.11.2020/20126

Etik Beyan

Ethical approval was obtained from the Harran University Clinical Research Ethics Committee (approval no: HRÜI20/14/27, date: August 17, 2020).

Investigation of Serum Plasma Total Oxidant/Antioxidant, Thiol-Disulfide, and Asprosin Levels in Fibromyalgia Patients

Öz

Background: Fibromyalgia is defined as a chronic syndrome of uncertain etiology, accompanied by musculoskeletal findings and numerous somatic symptoms. In this study, we aimed to contribute to understanding the etiopathogenesis of fibromyalgia syndrome by examining total antioxidant status, total oxidant status, thiol-disulfide homeostasis, and asprosin levels. Materials and Methods: Newly diagnosed female patients with fibromyalgia syndrome between the ages of 20-50 and healthy female volunteers in the same age range were included in the study. Plasma native thiol, total thiol, disulfide, native thiol/total thiol, disulfide/native thiol, disulfide/total thiol, total antioxidant level, total oxidant level, oxidative stress index, and asprosin values of both groups were measured. 
Results: Total antioxidant level, total oxidant level and total thiol levels were lower in the patient group; the disulfide/native thiol ratio was higher in the patient group; the differences were statistically significant (p=0.024, p<0.001, p=0.050, p=0.050). In the fibromyalgia syndrome group, there was a positive correlation between age and total antioxidant level and total thiol values (r=0.361, p=0.020; r=0.314, p=0.045, respectively) and a negative correlation with native thiol (r=0.354, p=0.023). There was a positive correlation between body mass index (BMI) and asprosin and total oxidative level in the fibromyalgia syndrome group (r=0.743, p<0.001; r=0.356, p=0.022, respectively); there was a negative correlation between BMI and total antioxidant level in the control group (r=0.429, p=0.005). The Widespread Pain Index was positively correlated only with asprosin (r=0.309, p=0.049). 
Conclusions: Although no significant difference was found between the groups in terms of serum asprosin levels in fibromyalgia syndrome, the positive correlations of asprosin with BMI and the Widespread Pain Index may suggest an association with metabolic status and pain extent. In addition, our findings indicate partial alterations in oxidative-antioxidative balance and thiol-disulfide homeostasis in fibromyalgia syndrome rather than a uniform disturbance across all parameters.

Anahtar Kelimeler

• Fibromyalgia
• oxidative stress
• adipokines
• biomarkers

Destekleyen Kurum

This study was supported with a kit provision by the Scientific Research Commission of HARRAN University (Project No: 20126, Date: November 23, 2020).

Proje Numarası

23.11.2020/20126

Etik Beyan

Ethical approval was obtained from the Harran University Clinical Research Ethics Committee (approval no: HRÜI20/14/27, date: August 17, 2020).

Kaynakça

1. 1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-72.
2. 2. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. National Fibromyalgia Guideline Advisory Panel. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119-26.
3. 3. Sindel D, Saral İ, Esmaeilzadeh S. Fibromiyalji sendromunda uygulanan tedavi yöntemleri. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2012;58(2):136-142.
4. 4. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-10.
5. 5. Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009;122:22-30.
6. 6. Ozgocmen S, Ozyurt H, Sogut S, Akyol O. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int. 2006;26(7):585-97.
7. 7. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, et al. Oxygen radicals and human disease. Ann Intern Med. 1987;107(4):526-45.
8. 8. Kuppusamy UR, Dharmani M, Kanthimathi MS, Indran M. Antioxidant enzyme activities of human peripheral blood mononuclear cells exposed to trace elements. Biol Trace Elem Res. 2005;106(1):29-40.

9. 9. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41(12):1819-28.
10. 10. Özcan O, Erdal H, Çakırca G, Yönden Z. Oxidative stress and its impacts on intracellular lipids, proteins and DNA. J Clin Exp Invest. 2015;6(3):331-6.
11. 11. Halliwell B, Gutteridge JM. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med. 1995;18(1):125-6.
12. 12. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112-9.
13. 13. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11.
14. 14. Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr. 2000;72(2):653-69.
15. 15. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-32.
16. 16. Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med. 2013;65:244-53.
17. 17. Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. J Biol Chem. 2013;288(37):26489-96.
18. 18. Jones DP, Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med. 2009;47(10):1329-38.
19. 19. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D- dimer. Thromb Haemost. 2000;83(3):416-20.
20. 20. Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep. 2006;11(3):131-5.
21. 21. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2006;26(7):598-603.
22. 22. Neyal M, Yimenicioglu F, Aydeniz A, Taskin A, Saglam S, Cekmen M, et al. Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg. 2013;115(6):736-40.
23. 23. Aktekin B. Fibromiyalji sendromlu olgularda tiyol/disülfit düzeylerinin oksidatif stres ve klinik parametreler ile ilişkisi [tıpta uzmanlık tezi]. Diyarbakır: Dicle Üniversitesi Tıp Fakültesi; 2019.
24. 24. Fidan F, Alkan BM, Uğurlu FG, Bozkurt S, Sezer N, Biçer C, et al. Dynamic thiol/disulphide homeostasis in patients with fibromyalgia. Arch Rheumatol. 2017;32(2):112-7.
25. 25. Karatas G, Gunduz R, Haskul I, Ustun B, Neselioglu S, Karatas F, et al. Dynamic thiol and disulphide homoeostasis in fibromyalgia. Arch Med Sci. 2019;16(3):597-602.
26. 26. Tuzcu A, Baykara RA, Alışık M, Omma A, Acet GK, Dogan E, et al. Alteration of thiol-disulphide homeostasis in fibromyalgia syndrome. Acta Med (Hradec Kralove). 2019;62(1):12-18.
27. 27. Kajimura S. Adipose tissue in 2016: Advances in the understanding of adipose tissue biology. Nat Rev Endocrinol. 2017;13(2):69-70.
28. 28. Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017;23(12):1444-53.
29. 29. Jain AK, Carruthers BM, van de Sande MI, Barron SR, Donaldson CS, Dunne JV, et al. Fibromyalgia syndrome: Canadian clinical working case definition, diagnostic and treatment protocols—a consensus document. J Musculoskelet Pain. 2003;11(4):3-107.
30. 30. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum. 1981;11(1):151-71.
31. 31. Selek S, Aslan M, Horoz M, Gur M, Erel O. Oxidative status and serum PON1 activity in beta-thalassemia minor. Clin Biochem. 2007;40(5-6):287-91.
32. 32. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113-22.
33. 33. Ugur K, Aydin S. Saliva and blood asprosin hormone concentration associated with obesity. Int J Endocrinol. 2019;2019:2521096.
34. 34. Ko JR, Seo DY, Kim TN, Park SH, Kwak HB, Ko KS, et al. Aerobic exercise training decreases hepatic asprosin in diabetic rats. J Clin Med. 2019;8(5):666.
35. 35. Deniz R, Yavuzkir S, Ugur K, Ustebay DU, Baykus Y, Ustebay S, et al. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome. J Obstet Gynaecol. 2021;41(2):279-84.
36. 36. Zhang H, Hu W, Zhang G. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease. Int Urol Nephrol. 2020;52(8):1517-22.
37. 37. Gozel N, Kilinc F. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin. Endokrynol Pol. 2021;72(1):37-43.
38. 38. BlokhKerpel A, Tiosano S, Amital D, Comaneshter D, Cohen AD, Amital H. Association of obesity, smoking and socioeconomic strata with the fibromyalgia syndrome. Harefuah. 2019;158(9):583-6.
39. 39. Üçeyler N, Burgmer M, Friedel E, Greiner W, Petzke F, Sarholz M, et al. Ätiologie und Pathophysiologie des Fibromyalgiesyndroms: aktualisierte Leitlinie 2017 und Übersicht von systematischen Übersichtsarbeiten sowie eine Übersicht über Studien zur Kleinfaserpathologie bei Subgruppen des FMS [Etiology and pathophysiology of fibromyalgia syndrome: updated guideline 2017, overview of systematic reviews and review of studies on small fiber pathology in subgroups of fibromyalgia syndrome]. Schmerz. 2017;31(3):239-45.
40. 40. Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M. Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int. 2009;29(6):629-33.